Sun Pharma & Rockwell Medical enter licensing agreement for Triferic in India

Triferic is the only USFDA-approved therapy in the U.S. indicated to replace iron and maintain haemoglobin in hemodialysis patients via dialysate during each dialysis treatment.

from India Infoline News Service https://ift.tt/2FPm2RB